A highly unusual structural evolution has been observed in temperature dependent studies of the fast ion conductor Ag 7 P 3 S 11 , using X-ray diffraction, Raman scattering, 31 P and 109 Ag NMR spectroscopy, and electrical conductivity measurements. At 205 K the high-temperature γ -phase (space group C2/c) undergoes a phase transition to an intermediate β-phase of different symmetry. At a temperature near 130 K another phase transition is observed resulting in the formation of an ordered low-temperature α-modification crystallizing in the same space group as the γ -phase. Restoration of the high-temperature-phase symmetry in the low-temperature phase is unambiguously confirmed by single-crystal X-ray structure determination and 31 P solid state NMR peak multiplicities. The re-entrant phase behavior is further supported by temperature dependent electrical conductivity measurements, which reveal that the activation energies of the dc conductivity for the α-and γ -phases are identical and significantly lower compared to those measured in the β-phase. Although the β-to γ -phase transition is associated with a change in enthalpy, those observables reflecting silver ion dynamics show no discontinuities at the phase transition temperature. The high-temperature γ -phase crystallizes in the monoclinic system, space group C2/c (No. 15), a = 23.999(2) Å, b = 6.3621(3) Å, c = 24.909(2) Å, β = 110.926(7) • , R = 0.0318 (300 K). The low-temperature α-phase is isostructural with a = 24.090(1) Å, b = 6.3400(3) Å, c = 24.581(1) Å, β = 110.870(6) • , R = 0.0317 (120 K). Contrary to the situation in γ -Ag 7 P 3 S 11 , all the silver atoms are well-localized in the α-phase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.